Evidence map›Paper›PMID 41603547›Full record

ArticleThe ISME journal2026

Cefiderocol resistance genes identified in environmental samples using functional metagenomics.

Remi Gschwind, Mehdi Bonnet, Anna Abramova, Victor Hugo Jarquín-Díaz, Marcus Wenne, Ulrike Löber, Nicolas Godron, Ioannis D Kampouris, Faina Tskhay, Fouzia Nahid and 9 more

Abstract read
In one paragraph

Article in The ISME journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Remi GschwindUniversité Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME, 16 rue Henri Huchard, Paris F-75018, France.ORCID 0000-0001-7741-9764
Mehdi BonnetUniversité Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME, 16 rue Henri Huchard, Paris F-75018, France.
Anna AbramovaDepartment of Infectious Diseases, Institute of Biomedicine The Sahlgrenska Academy, University of Gothenburg, Guldhedsgatan 10, Gothenburg SE-413 46, Sweden.
Victor Hugo Jarquín-DíazExperimental and Clinical Research Center, a cooperation between the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Charitépl. 1, 10117 Berlin, Germany.
Marcus WenneDepartment of Infectious Diseases, Institute of Biomedicine The Sahlgrenska Academy, University of Gothenburg, Guldhedsgatan 10, Gothenburg SE-413 46, Sweden.
Ulrike LöberExperimental and Clinical Research Center, a cooperation between the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Charitépl. 1, 10117 Berlin, Germany.ORCID 0000-0001-7468-9531
Nicolas GodronUniversité Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME, 16 rue Henri Huchard, Paris F-75018, France.
Ioannis D KampourisTechnische Universität Dresden, Institute of Hydrobiology, Zellescher Weg 40, Dresden, 01217, Germany.
Faina TskhayTechnische Universität Dresden, Institute of Hydrobiology, Zellescher Weg 40, Dresden, 01217, Germany.
Fouzia NahidDepartment of Microbiology, Faculty of Biological Sciences, Quaid-i-Azam University, University Rd, Islamabad, Pakistan.
Chloé DebrouckerUniversité Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME, 16 rue Henri Huchard, Paris F-75018, France.
Maximilien Bui-HaiUniversité Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME, 16 rue Henri Huchard, Paris F-75018, France.
Inès El AibaUniversité Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME, 16 rue Henri Huchard, Paris F-75018, France.
Uli KlümperTechnische Universität Dresden, Institute of Hydrobiology, Zellescher Weg 40, Dresden, 01217, Germany.ORCID 0000-0002-4169-6548
Thomas U BerendonkTechnische Universität Dresden, Institute of Hydrobiology, Zellescher Weg 40, Dresden, 01217, Germany.
Sofia K Forslund-StartcevaExperimental and Clinical Research Center, a cooperation between the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Charitépl. 1, 10117 Berlin, Germany.
Rabaab ZahraDepartment of Microbiology, Faculty of Biological Sciences, Quaid-i-Azam University, University Rd, Islamabad, Pakistan.
Johan Bengtsson-PalmeDepartment of Infectious Diseases, Institute of Biomedicine The Sahlgrenska Academy, University of Gothenburg, Guldhedsgatan 10, Gothenburg SE-413 46, Sweden.ORCID 0000-0002-6528-3158
Etienne RuppéUniversité Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME, 16 rue Henri Huchard, Paris F-75018, France.

Funding

Establishing a Monitoring Baseline for Antibiotic Resistance in Key Environments
6 · The paper itself

Abstract

Antibiotic resistance poses a global public health threat, which can originate from the transfer of environmental antibiotic resistance genes to pathogenic bacteria, as highlighted by the "One Health" framework. Cefiderocol is a siderophore cephalosporin recently introduced in clinical practice which displays a "Trojan Horse" mechanism, utilizing bacterial iron transportation systems for cell entry. Although it is only used as a last-line antibiotic, resistance has already been observed in clinical isolates. Yet, cefiderocol resistance genes are difficult to monitor as resistance mechanisms remain mostly undescribed in antibiotic resistance gene databases and therefore uncharacterized in the environment. To address this critical gap, we applied functional metagenomics to diverse environmental samples (wastewater, freshwater, and soil) from France, Germany, Sweden, and Pakistan. Four antibiotic resistant genes were identified as responsible for increased cefiderocol minimum inhibitory concentrations to clinically-relevant levels (ranging from 1 to 4 mg/l), including ꞵ-lactamases (VEB-3, OXA-372 homolog, and YbxI homolog) and a partial penicillin-binding protein homolog. None of these genes had been previously reported as a cefiderocol resistance gene. Three out of four had their closest homologs in pathogenic bacteria. The blaVEB-3 gene was associated with a mobile genetic element and distributed across all wastewater metagenomes analyzed in this study. We therefore highlight the critical need for functional metagenomics, to characterize previously uncharacterized last-line antibiotic resistance mechanisms which will be used to enrich antibiotic resistance gene databases and thereby improving antibiotic resistance surveillance in all One Health compartments.

Indexed as

Anti-Bacterial AgentsBacteriaCephalosporinsDrug Resistance, BacterialMetagenomicsCefiderocolMicrobial Sensitivity TestsAnti-Bacterial AgentsCefiderocolCephalosporinsantibiotic resistancecefiderocolfunctional metagenomics

Identifiers

PMID41603547
PMCPMC12915585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.